Renaissance Technologies - IMPAX LABORATORIES INC ownership

IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 198 filers reported holding IMPAX LABORATORIES INC in Q4 2016. The put-call ratio across all filers is 269.00 and the average weighting 0.1%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of IMPAX LABORATORIES INC
ValueSharesWeighting
Q2 2018$6,636,0000.0%341,2000.0%0.00%
-42.9%
Q1 2018$6,636,000
-68.8%
341,200
-73.3%
0.01%
-69.6%
Q4 2017$21,300,000
+66.5%
1,279,300
+103.0%
0.02%
+53.3%
Q3 2017$12,791,000
+119.4%
630,100
+74.0%
0.02%
+114.3%
Q2 2017$5,831,000
-15.3%
362,200
-33.4%
0.01%
-30.0%
Q1 2017$6,883,000
-52.5%
544,100
-50.2%
0.01%
-56.5%
Q4 2016$14,482,000
+243.9%
1,093,002
+515.1%
0.02%
+228.6%
Q3 2016$4,211,000
+11.7%
177,700
+51.0%
0.01%0.0%
Q1 2016$3,769,000
+5.2%
117,700
+40.5%
0.01%
-12.5%
Q4 2015$3,583,000
+453.8%
83,800
+494.3%
0.01%
+700.0%
Q2 2015$647,000
-80.8%
14,100
-80.4%
0.00%
-85.7%
Q1 2015$3,370,000
+73.3%
71,900
+17.1%
0.01%
+40.0%
Q4 2014$1,945,000
+108.2%
61,400
+55.8%
0.01%
+66.7%
Q3 2014$934,000
-96.6%
39,400
-96.2%
0.00%
-95.5%
Q1 2014$27,635,000
-21.9%
1,046,000
-25.7%
0.07%
-22.4%
Q4 2013$35,405,000
+62.4%
1,408,300
+32.2%
0.08%
+60.4%
Q3 2013$21,805,000
+15.6%
1,065,200
+12.6%
0.05%
+8.2%
Q2 2013$18,867,000946,3000.05%
Other shareholders
IMPAX LABORATORIES INC shareholders Q4 2016
NameSharesValueWeighting ↓
Orbimed Advisors 5,415,600$162,414,0001.91%
Broadfin Capital, LLC 1,217,858$36,524,0001.80%
NEW AMSTERDAM PARTNERS LLC/NY 695,100$20,846,0001.36%
Healthcare Value Capital, LLC 50,000$1,500,0001.26%
Iguana Healthcare Management, LLC 75,000$2,249,0001.05%
Matarin Capital Management, LLC 78,292$2,347,977,0001.04%
Independence Capital Asset Partners, LLC 253,089$7,590,0001.04%
Tekla Capital Management LLC 344,683$10,337,0000.95%
Penn Capital Management Company, LLC 794,641$23,831,0000.92%
Leonard Capital Management, Inc. 87,661$2,629,0000.89%
View complete list of IMPAX LABORATORIES INC shareholders